Compound Evidence File
#EC-2026-0114
Trenbolone Acetate
Filed under Injectable Oils. The bureau holds 146 laboratory returns for this compound from 44 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
44 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 6 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 5 | 10.0 | 9.9 | 10.0 | 21 Nov 2025 | 7 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 10.0 | 9.9 | 10.0 | 26 Feb 2026 | 3 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 10.0 | 9.9 | 10.0 | 21 Feb 2026 | 20 May 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 10.0 | 9.9 | 10.0 | 12 Apr 2026 | 6 Jun 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 10.0 | 9.9 | 10.0 | 25 May 2026 | 4 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 10.0 | 9.9 | 10.0 | 12 Jan 2026 | 4 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 10.0 | 9.9 | 10.0 | 23 May 2026 | 1 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 10.0 | 9.9 | 10.0 | 9 Apr 2026 | 5 Jun 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 10.0 | 10.0 | 10.0 | 6 Feb 2026 | 24 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 9.9 | 9.9 | 10.0 | 16 Jan 2026 | 11 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 9.9 | 9.9 | 10.0 | 8 Nov 2025 | 28 Apr 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 9.9 | 9.9 | 10.0 | 2 Dec 2025 | 11 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 9.9 | 9.9 | 10.0 | 7 Jan 2026 | 23 Apr 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 9.9 | 9.9 | 10.0 | 2 Apr 2026 | 12 Aug 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 9.9 | 9.9 | 10.0 | 4 May 2026 | 21 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 9.9 | 9.9 | 10.0 | 27 Apr 2026 | 18 Aug 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 9.9 | 9.9 | 10.0 | 11 Nov 2025 | 3 May 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 9.9 | 9.9 | 10.0 | 5 Dec 2025 | 14 Aug 2026 |
| AsymchemCASE #VI-2026-0091 | A | 3 | 9.9 | 9.9 | 10.0 | 25 Jul 2026 | 9 Aug 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 9.9 | 9.9 | 10.0 | 1 May 2026 | 13 Jul 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 9.9 | 9.9 | 10.0 | 10 May 2026 | 11 Jul 2026 |
| Kits4lessCASE #VI-2026-0744 | X | 1 | 9.6 | 9.6 | 9.6 | 20 Jun 2025 | 20 Jun 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 3 | 9.0 | 8.6 | 9.3 | 25 May 2026 | 25 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 7 | 8.7 | 7.4 | 10.0 | 23 May 2026 | 23 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 4 | 8.5 | 8.0 | 9.2 | 25 May 2026 | 25 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 5 | 8.1 | 6.2 | 10.0 | 21 May 2026 | 21 May 2026 |
| Dankang BioHealthCASE #VI-2026-0775 | X | 1 | 8.0 | 8.0 | 8.0 | 8 Jul 2025 | 8 Jul 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 8 | 7.8 | 6.2 | 9.4 | 25 May 2026 | 25 May 2026 |
| Biolongevity LabsCASE #VI-2026-0442 | X | 2 | 7.8 | 7.7 | 7.8 | 13 Feb 2025 | 21 May 2026 |
| M-PeptidesCASE #VI-2026-0442 | X | 1 | 7.8 | 7.8 | 7.8 | 17 Dec 2024 | 17 Dec 2024 |
| NextGen HealthCASE #VI-2026-0604 | X | 1 | 7.6 | 7.6 | 7.6 | 28 Mar 2025 | 28 Mar 2025 |
| UtherCASE #VI-2026-0902 | X | 3 | 7.2 | 5.5 | 8.9 | 24 Apr 2025 | 17 May 2026 |
| UWA Elite PeptidesCASE #VI-2026-0130 | X | 1 | 7.2 | 7.2 | 7.2 | 14 Jan 2025 | 14 Jan 2025 |
| Shandong Shengyuan Peptide TechnologyCASE #VI-2026-0634 | X | 1 | 7.0 | 7.0 | 7.0 | 25 Apr 2025 | 25 Apr 2025 |
| Mix PeptidesCASE #VI-2026-0699 | X | 1 | 6.9 | 6.9 | 6.9 | 28 Mar 2025 | 28 Mar 2025 |
| ScienceCASE #VI-2026-0636 | X | 1 | 6.6 | 6.6 | 6.6 | 11 Jun 2025 | 11 Jun 2025 |
| Qing Li PeptideCASE #VI-2026-0469 | X | 15 | 6.5 | 3.2 | 9.6 | 9 Jun 2025 | 24 May 2026 |
| Pure RawzCASE #VI-2026-0767 | X | 2 | 6.2 | 6.2 | 6.3 | 11 Jun 2025 | 25 May 2026 |
| DeuschemCASE #VI-2026-0004 | X | 1 | 5.9 | 5.9 | 5.9 | 28 Mar 2025 | 28 Mar 2025 |
| Zhang TYCASE #VI-2026-0070 | X | 1 | 3.9 | 3.9 | 3.9 | 16 Mar 2025 | 16 Mar 2025 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | X | 1 | 3.7 | 3.7 | 3.7 | 2 Jul 2025 | 2 Jul 2025 |
| Advanced Technology and IndustrialCASE #VI-2026-0133 | X | 1 | 1.7 | 1.7 | 1.7 | 13 Feb 2025 | 13 Feb 2025 |
Open any subject to view the batch-level evidence for Trenbolone Acetate alone.